Heartbeat Valuation Estimate
Heartbeat Valuation as of Last Funding Round
Heartbeat Company Overview
Heartbeat Medical is a healthcare technology company that focuses on patient-reported outcome measures (PROMs). Their outcome measurement platform enables healthcare providers, payers, medical devices, and pharmaceutical companies to evaluate how treatments impact patients' quality of life. Heartbeat Medical's platform aims to enhance clinical practice in real-time, improve care quality standards, comply with regulatory requirements, and implement value-based initiatives. The company provides up-to-date resources on PROMs and real-world data, including blogs, whitepapers, and case studies
Heartbeat Valuation History
Heartbeat Stock Price
The stock price of Heartbeat can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Heartbeat has issued 250 million shares, at the estimated UpMarket valuation of $29.49 million, each share of Heartbeat stock would be worth $0.12.
Buy Heartbeat Stock
If you would like to buy shares in Heartbeat, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Heartbeat stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Heartbeat as well.
Heartbeat Management
| Name | Position |
|---|---|
| Yannik Schreckenberger | CEO |
| Dr. med. Valerie Kirchberger | COO |
